May 23, 2021 – The Centers for Medicare & Medicaid Services (CMS) has determined that the evidence is sufficient to conclude that the use of implantable cardioverter defibrillators (ICDs, also referred to as defibrillators) is reasonable and necessary for the treatment of illness or injury or to improve the functioning of a malformed body member under section 1862(a)(1)(A) of the Social Security Act.
Topic
- Coding
- Reimbursement
Resource Type
- Guidelines & Protocols
Related Resources
Guidelines & Protocols
Carelon Considers Add-on Ablation Code 93657 Not Medically Necessary
Effective March 1, 2026, Carelon Medical Benefits Management will update clinical guidelines for additional linear or focal intracardiac catheter ablation (CPT 93657) of the left…
February 3, 2026
Guidelines & Protocols
Process and Timeline for Device Manufacturers Seeking Assistance with Creating CPT Codes
The Heart Rhythm Society (HRS) welcomes the opportunity to engage with device manufacturers to assist with development of CPT codes for heart rhythm services and…
December 16, 2025
Guidelines & Protocols
Government Shutdown Impact on Medicare Claims
As the federal government shutdown continues, the Centers for Medicare & Medicaid Services (CMS) has issued updated guidance instructing all Medicare Administrative Contractors (MACs) to…
October 15, 2025